Neuroguard
Payments companies reported to CMS as associated with Neuroguard. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Neuroguard, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Neuroguard
These are the largest totals companies reported as associated with Neuroguard. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Eric Secemsky | Boston, MA | Interventional Cardiology | $5,156.93 |
| Santhosh Mathews | Bradenton, FL | Interventional Cardiology | $4,700.00 |
| Peter Soukas | Providence, RI | Interventional Cardiology | $4,000.00 |
| Tudor Jovin | Pennington, NJ | Neurocritical Care | $4,000.00 |
| Michael Jolly | Columbus, OH | Interventional Cardiology | $2,112.34 |
| Ramzan Zakir | New Brunswick, NJ | Cardiovascular Disease | $1,007.50 |
| Mitchell Silver | Columbus, OH | Interventional Cardiology | $521.98 |
| Ravish Sachar | Raleigh, NC | Interventional Cardiology | $269.05 |
| Nicolas Mouawad | West Branch, MI | Vascular Surgery | $56.67 |
| Taylor Brenz | Bay City, MI | Physician Assistant | $56.66 |
Prescribed Neuroguard?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.